Skip to content

BHIVA clinicians Retroviruses roundtable feedback - Monday

Lisbon conference news: Nevirapine performs strongly in high viral load patients

Thailand to start producing own version of d4T

Hydroxyurea - when is the best time to use it?

Risk of interactions between Zyban & HAART

Taking Heart: biggest ever survey of UK HIV+ makes fascinating reading

Twice daily nelfinavir approved in US

Delavirdine not associated with lipid increases in newly treated

Ritonavir mini-dose improves efavirenz/amprenavir salvage prospects

Tenofovir: low resistance risk for new drug after six months therapy

HAART in the real world: Swiss findings

Comprehensive Geneva conference summaries

Therapeutic drug monitoring: better test for NRTIs?

AIDS dementia rate rises in Sydney, but falls in London

Nevirapine liver toxicity: US reminder issued

Understanding unsafe sex in the age of HAART

Handy medication schedule software for pharmacies

UK heterosexual HIV diagnoses overtake gay men for first time